Profile_bird

Hey there! AlaVax is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What's happening? Join today to start receiving AlaVax's tweets.

Already using Twitter
from your phone? Click here.

AlaVax

  1. encourages everyone who is eligible to consider taking part in a vaccine study to help end HIV.Check our HopeTakesAction.org for a location.
  2. The Vaccine Research Clinic at UAB needs healthy men who are btw the ages of 19-45 to participate in a study to test a new HIV vaccine.
  3. needs volunteers to participate in HIV Vaccine trials in the Bham area.
  4. Reaching out to African Americans & other minorities who are disproportionately affected by HIV. Your participation is needed in vax trials!
  5. Volunteers will be compensated for time and travel.
  6. Men who have sex with men living in Bham Al are needed to participate in a new vaccine trial. You cannot contract HIV from the study.
  7. Ready to speak with people living in the Birmingham area about vaccine studies to hopefully prevent HIV !
  8. Alabama Vaccine Research Clinic needs HIV neg men who have sex with other men to participate in a vaccine trial. Go to: HopeTakesAction.org
  9. The Alabama Vaccine Research Clinic welcomed a new volunteer to screen for HVTN 505 today. www.hopetakesaction.org
  10. Getting the day started. Ready to speak with YOU about HIV vaccine clinical trials. Hit me up ! :)
  11. Concluded the morning session on results of previous trials and moving forward with new direction.
  12. AVRC staff completes day 1 of HVTN Recruitment Workshop and conducts outreach activity on the streets of Chicago.Great learning experience!
  13. Check out www.hopetakesactiion.org to see how YOU can help end the HIV epidemic.
  14. AVRC staff members are enroute to Chicago for a three days of training related to the launch of our latest vaccine effort, HVTN 505.
  15. The Alabama Vaccine Research Clinic has begun enrollment for a new study.